Suzhou Medical System Technology603990.SHValuation Analysis

As of Oct 19, 2026, Suzhou Medical System Technology (603990.SH) trades at a P/E of 332.00x, P/B of 6.90x, P/S of 23.50x, and a dividend yield of 0.00%.
Longitudinal percentile comparison: P/E sits at the 92nd percentile over the trailing 10Y window (vs. 51st percentile over 3Y); P/B sits at the 68th percentile over the trailing 10Y window (vs. 85th percentile over 3Y); P/S sits at the 84th percentile over the trailing 10Y window (vs. 84th percentile over 3Y).
Cross-sectional valuation: its P/E ranks at the 92nd percentile within its industry and the 95th percentile across the broader market.
Shareholder return highlight: Total Shareholder Yield is 0.00%; its historical percentile over the trailing long-term window is still accumulating data.
The P/E and P/B percentiles diverge here, differing by 23.8 points — relying on either metric alone could be misleading. Its P/E percentile is roughly the same whether measured against the industry or the broader market. Shareholder returns here are driven almost entirely by cash dividends, with minimal contribution from buybacks. Suzhou Medical System Technology operates in the Computer sector. Data refreshes weekly and is for reference only, not investment advice.